The next step in the authorisation procedure is for ECHA to propose to the European Commission which substances should be prioritised for inclusion into the authorisation list. On the 18th of November 2015 HHPA and MHHPA were included in the draft recommendation for inclusion in the authorisation list. This draft recommendation was open for public consultation until the 18th of February. The ECHA member state committee, comprising of delegates from all national competent authorities, will now discuss this prioritisation and are expected to provide their opinion on October 2016.
Recent Publications
- AJIT Voluntary Commitment Progress Report 2020 (final version)
- AJIT Voluntary Commitment Progress Report 2020
- AJIT Voluntary Commitment Progress Report 2019 (final version)
- Voluntary Commitment Progress Report 2019
- Voluntary Commitment Progress Report 2018
- Voluntary Commitment Report 2017
- ECHA Excludes Anhydrides from 7th Prioritisation for Authorisation
- Exposure and Medical Inventory Report
- AJIT Public Consultation Report
- 7th Draft Prioritisation for Authorisation